Issue 12, 2006

Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs

Abstract

A linear type of several low molecular weight CXCR4 antagonists were developed based on T140 analogs, which were previously found to be strong CXCR4 antagonists that block X4-HIV-1 entry and have inhibitory activities against cancer metastasis/progression and rheumatoid arthritis.

Graphical abstract: Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs

Supplementary files

Article information

Article type
Communication
Submitted
14 Mar 2006
Accepted
24 Apr 2006
First published
12 May 2006

Org. Biomol. Chem., 2006,4, 2354-2357

Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs

H. Tamamura, H. Tsutsumi, H. Masuno, S. Mizokami, K. Hiramatsu, Z. Wang, J. O. Trent, H. Nakashima, N. Yamamoto, S. C. Peiper and N. Fujii, Org. Biomol. Chem., 2006, 4, 2354 DOI: 10.1039/B603818B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements